http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2145402-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_266a03d61c432b4a6039464e701e8a85 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| filingDate | 1971-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2145402-A1 |
| titleOfInvention | Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia |
| abstract | Magnesium acetylglycinate hexa-hydrate, for the treatments of hypomagnesaemia without the side-effects associated with the use of magnesium chloride and magnesium orotate-lactate. The oral mouse LD50 is 17.5g/kg. Blood levels in rabbits are slightly lower than those after MgCl2 but better than after magnesium lactate. Clinical effects are good and the salt was well tolerated. Prepd. by neutralization of aceylglycine with MgCO3. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4196196-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4562205-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0130644-A1 |
| priorityDate | 1971-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.